Brown Advisory’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.4M Sell
1,259,174
-377,962
-23% -$12.3M 0.08% 199
2025
Q4
$49.3M Sell
1,637,136
-121,951
-7% -$3.45M 0.07% 205
2025
Q3
$46.1M Buy
1,759,087
+76,611
+5% +$1.83M 0.06% 211
2025
Q2
$35.9M Buy
1,682,476
+79,652
+5% +$1.8M 0.05% 240
2025
Q1
$34.1M Buy
1,602,824
+8,870
+0.6% +$182K 0.05% 237
2024
Q4
$32.3M Buy
+1,593,954
New +$32.9M 0.04% 270

Other funds holding GRDN

Brown Advisory's GRDN Position: Q1 2026 in Review

Brown Advisory reduced its Guardian Pharmacy Services (GRDN) stake by 23% in Q1 2026, selling an estimated $12.3M and leaving 1,259,174 shares worth $47.4M. The position accounts for 0.08% of the portfolio, ranked #199.

Brown Advisory first reported a position in GRDN in Q4 2024 and has held it in 6 quarters since. The position peaked at $49.3M in Q4 2025. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Brown Advisory held 1,259,174 shares of Guardian Pharmacy Services worth $47.4M as of Q1 2026.
  • Brown Advisory sold 377,962 Guardian Pharmacy Services shares in Q1 2026, an estimated $12.3M.
  • Guardian Pharmacy Services made up 0.08% of Brown Advisory's portfolio in Q1 2026, its #199 holding.
  • Brown Advisory first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 6 quarters since.
  • Brown Advisory's Guardian Pharmacy Services position peaked at $49.3M in Q4 2025.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.